ResearchMoz

Biopharmaceutical Market Research Reports & Industry Analysis

In a simple definition, Biopharmaceutical is described as a drug that is produced by the means of biotechnology. Biopharmaceuticals are therapeutic agents aimed to treat a variety of diseases and disorders/or symptoms in a body. These drugs are not produced from any chemical reactions or a native or synthesized biological source, but are created using living organisms such as yeast, bacteria, and mammalian cells that may have been modified to create the desired component or compound. They are proteins DNA, RNA, nucleic acids used for vivo diagnostic or therapeutic purposes. 
The very first biopharmaceutical drug that was introduced and approved for therapeutic use in the field of medicine was the recombinant (artificial) human insulin. This drug was released in the year 1982 for use by diabetics.  
Biopharmaceuticals are extremely promising and effective for treating some of the most intractable medical conditions, such as autoimmune and cancer diseases. Biopharmaceuticals are created using certain typical methods, their cost to research, develop, manufacture, and administer is really high. As a result, the drugs are placed at the high price tags. 
According to the biotechnology industry, over 400 biopharmaceutical products are treating over 200 diseases in clinical trials, some of which do not even have treatments. Over the past few years, the FDA has approved biopharmaceutical products for a number of reasons and a range of medical conditions. Due to this legitimate rule, the outflows on biopharmaceuticals have increased, rather doubled from a figure of $35 billion to $73 billion. And to this day, this market has continued to flourish and explore in terms of great advancements and scientific achievements. 
Look up for more related information on Biopharmaceuticals in the flesh of intelligent market research reports featured on ResearchMoz. 

Biopharmaceutical

Browse reports in Biopharmaceutical

Displaying 1 to 30 (of 32 records)
Global and China Urinary System Agents Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Urinary System Agents basic information included Urinary System Agents definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence,  Urinary System Agents industry policy and plan,  Urinary System...
$2200
Global and China Auxiliaries and Other Medicinal Chemicals Industry 2014 Market Research Report
Feb 2014   |   By - QYResearch
The report firstly introduced Auxiliaries and Other Medicinal Chemicals basic information included Auxiliaries and Other Medicinal Chemicals definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Auxiliaries and Other Medicinal...
$2200
Bigpharma Deals and Alliances of 2013
Feb 2014   |   By - Current Partnering
The Bigpharma Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.   Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view...
$1495
Global and China MABS Industry 2014 Market Research Report
Jan 2014   |   By - QYResearch
The report firstly introduced MABS basic information included MABS definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, MABS industry policy and plan, MABS product specification, manufacturing process, cost structure etc. then statistics...
$2200
Biopharmaceutical Companies (Global) - Industry Report
Jan 2014   |   By - Plimsoll Publishing Ltd.
Plimsoll Publishing’s Biopharmaceutical Companies (Global) Analysis provides a detailed overview of the Biopharmaceutical Companies (Global) market and delivers a comprehensive individual analysis on the top 180 companies, including BAXTER INTERNATIONAL INC, DONG-A PHARMACEUTICAL CO.,LTD. and STALLERGENES SA.  This report includes a wealth of information on the...
$1425
Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013
Dec 2013   |   By - Espicom
The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition. The major players include Hospira, Sandoz (Novartis), Hikma Pharmaceuticals, Fresenius Kabi and Teva Pharmaceutical Industries. But interest in generic injectables has not been limited to established generic...
$1740
Biological and Biosimilars Drug Market in Poland 2013
Aug 2013   |   By - PMR
Examine the future of biologics in the Polish pharma market. Report surveys biologic and biosimilar drugs, epidemiology and growth potential 2013- 2015. In Poland, as in many parts of the world, a growing number of patients are being treated using biological or biosimilar drugs. The list of illnesses for which these drugs are prescribed includes psoriasis, Crohns disease, colitis,...
$2660
Array Biopharma Partnering 2005-2013
Jul 2013   |   By - Current Partnering
The Partnering Agreements with Intermune 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.   This report provides all the information you require to better understand Intermune and its partnering interests and activities over the past seven years.   On demand company...
$995
Competitive Information Service Package - 1-year subscription
May 2013   |   By - La Merie Publishing
Subscription to this product provides access during one year to three Competitive Intelligence information products released by La Merie Publishing with great cost savings: 1) Flat-Rate Access to La Merie Publishing Reports: Access during one year to all existing and new reports produced by La Merie Publishing and listed in the online store. Among La Merie Publishing...
$7871
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
May 2013   |   By - La Merie Publishing
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and...
$2092
Global Interventional Cardiology Devices - Market Growth Analysis, 2009-2015
Apr 2013   |   By - Axis Research Mind
Global interventional cardiac devices industry forecasts to reach at US$15.7 billion by 2015 at a high CAGR of 9.9% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims nearly 25% of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.9% driving a market value of US$5 billion by 2015. ...
$3270
Distribution on the pharmaceutical market in Poland 2013
Mar 2013   |   By - PMR
The distribution network for pharmaceutical products in Poland is made up of several main channels, including wholesale, pharmacy, non-pharmacy and direct and online sales. Pharmacy memberships in larger chains have been on the rise and are expected to continue to expand in the coming years. Find out which specific market developments and trends are causing this shift, and...
$2660
China Human Factor IX Industry 2013 Market Research Report
Feb 2013   |   By - QYResearch
The report firstly introduced Human Factor IX basic information included Human Factor IX definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Human Factor IX industry policy and plan, Human Factor IX product specification,...
$2000
Chinese Markets for Biopharmaceuticals
Nov 2012   |   By - Asia Market Information & Development Company
China's demand for biopharmaceuticals has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006...
$2000
Erythropoietin (EPO) Market Report: 2012 Edition
Sep 2012   |   By - Koncept Analytics
With the advent of novel technology, companies operating in the healthcare/science/pharmaceutical/therapeutic area are now scaling new heights. Also this industry is boosted by the rising number of incidences of health related issues emanating from the changing lifestyle and rapidly evolving surrounding environment. Amongst the respective industries of biological sciences, an...
$800
Top 200 Biopharmaceutical Companies (Global)
Jul 2012   |   By - Plimsoll Publishing Ltd.
This report is an in-depth financial evaluation of the GlobalBiopharmaceutical Companies. Using the unique Plimsoll method of analysis, each of the top 200 companies included is individually assessed and ranked against each other and compared to industry averages.Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial...
$1500
Insulin - Global
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in global markets. The analyses provide essential market information for decision-makers including:  Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Bulgaria, Canada, Chile, China, Colombia, Czech...
$25922
Insulin - Europe
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in European markets. The analyses provide essential market information for decision-makers including:  Armenia, Austria, Azerbaijan, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary,...
$14640
Insulin - Asia
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Asian markets. The analyses provide essential market information for decision-makers including:  Bangladesh, China, India, Indonesia, Iran, Japan, Jordan, Kazakhstan, Kyrgyzstan, Lebanon, Malaysia, Mongolia, Nepal, Oman, Pakistan,...
$10620
Insulin - Americas
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in American markets. The analyses provide essential market information for decision-makers including:  Argentina, Bolivia, Canada, Chile, Colombia, Ecuador, Mexico, Panama, Peru and United States Overall market value for...
$5044
Insulin - Africa
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in African markets. The analyses provide essential market information for decision-makers including:  Egypt, Eritrea, Ethiopia, Ghana, Morocco, Nigeria, Senegal, South Africa, Sudan and Uruguay Overall market value for insulin...
$5044
Insulin - Eastern Europe
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Eastern European markets. The analyses provide essential market information for decision-makers including:  Armenia, Azerbaijan, Bulgaria, Czech Republic, Estonia, Georgia, Greece, Hungary, Latvia, Lithuania, Macedonia, Moldova,...
$9583
Insulin - Western Europe
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in Western European markets.  The analyses provide essential market information for decision-makers including: Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden and United...
$6990
Insulin - Top 10 Global Markets
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 10 global markets. The analyses provide essential market information for decision-makers including: United States, China, Japan, India, Germany, Russia, United Kingdom, France, Italy and Mexico Overall market value for insulin by...
$5044
Insulin - Top 5 European Markets
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 European markets. The analyses provide essential market information for decision-makers including: Germany, Russia, United Kingdom, France and Italy   Overall market value for insulin by country Overall market volume for...
$2451
Insulin - Top 5 Asian Markets
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 Asian markets. The analyses provide essential market information for decision-makers including: China, Japan, India, South Korea and Indonesia Overall market value for insulin by country Overall market volume for insulin by country...
$2451
Insulin - Top 5 American Markets
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 American markets. The analyses provide essential market information for decision-makers including: United States, Mexico, Canada, Argentina and Colombia Overall market value for insulin by country Overall market volume for insulin by...
$2451
Insulin - Top 5 African Markets
May 2012   |   By - Global Research & Data Services
This market research report package offers an in-depth perspective on the actual market situation, trends and future outlook for insulin in top 5 African markets. The analyses provide essential market information for decision-makers including: Egypt, Nigeria, Morocco, Sudan and Ethiopia Overall market value for insulin by country Overall market volume for insulin by country...
$2451
Research Report on Chinese Bio-pharmaceutical Industry, 2012
Mar 2012   |   By - China Research and Intelligence Co., Ltd. (CRI)
In China, biological products consist of vaccines, blood products, cytokine, diagnostic reagents and other active agents (including toxins, antigens, allergen, and recombinant DNA products, etc.). In China, animal vaccine belongs to veterinary medicine rather than biopharmaceutical industry. "Biopharmaceutical" in the report only refers to human biological products. Chinese...
$3000
Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
May 2011   |   By - GBI Research
GBI Research has released its research Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues. It provides a comprehensive overview of the generic drugs market, analysis of upcoming noteworthy patent expirations, and trends and issues facing the generics market.  The report delves into much detail on the current...
$3500
 
Displaying 1 to 30 (of 32 records)

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com

Popular Publishers

Transparency Market Research
ICD Research
Technavio
 
GBI Research
Winter Green Research
GlobalData